Satoshi Fujii

6PUBLICATIONS
38CO-AUTHORS
Molecular targetsHaematological tumoursOncology and carcinogenesis not elsewhere classifiedPredictive and prognostic markersCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 17, 2025
Artificial Intelligence-Powered Human Epidermal Growth Factor Receptor 2 and Tumor Microenvironment Analysis in Human Epidermal Growth Factor Receptor 2-Amplified Metastatic Colorectal Cancer: Exploratory Analysis of Phase II TRIUMPH Trial.

Mitsuho Imai, Yoshiaki Nakamura, Sangwon Shin

|Aug 01, 2024
Trastuzumab Deruxtecan in Advanced Solid Tumors With Human Epidermal Growth Factor Receptor 2 Amplification Identified by Plasma Cell-Free DNA Testing: A Multicenter, Single-Arm, Phase II Basket Trial.

Masataka Yagisawa, Hiroya Taniguchi, Taroh Satoh

|Oct 19, 2020
FMS-like tyrosine kinase 3 (FLT3) amplification in patients with metastatic colorectal cancer.

Hiroko Hasegawa, Hiroya Taniguchi, Yoshiaki Nakamura

|Jul 11, 2020
Optimization of therapeutic strategy for p16-positive oropharyngeal squamous cell carcinoma: Multi-institutional observational study based on the national Head and Neck Cancer Registry of Japan.

Yuki Saito, Ryuichi Hayashi, Yoshiyuki Iida

|Mar 31, 2018
Pathological tumor regression grade of metastatic tumors in lymph node predicts prognosis in esophageal cancer patients.

Tomohiro Kadota, Ken Hatogai, Tomonori Yano

|Jan 27, 2018
Comparison of MR Imaging and Dual-Energy CT for the Evaluation of Cartilage Invasion by Laryngeal and Hypopharyngeal Squamous Cell Carcinoma.

H Kuno, K Sakamaki, S Fujii

Pageof 1

Frequent Collaborators

2 joint publications

Yoshiaki Nakamura

2 joint publications

Takayuki Yoshino

2 joint publications

Hideaki Bando

2 joint publications

Yoshito Komatsu